Treatment of dementia-associated agitation with Gabapentin

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 1, 2000, Pages 40-43

  Roane, David M ^a   Feinberg, Todd E ^a   Meckler, Laurie ^a   Miner, Christian R ^a   Scicutella, Angela ^a   Rosenthal, Richard N ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CLINICAL TRIAL; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033960477     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.1.40     Document Type: Article

References (20)

1. Rabins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA 1982; 248:333-335
2. Deutsch LH, Rovner BW: Agitation and other noncognitive abnormalities in Alzheimer's disease. Psychiatr Clin North Am 1991; 14:341-351
3. Cohen-Mansfield J, Billing N: Agitated behaviors in the elderly: a conceptual review. J Am Geriatr Soc 1986; 34:711-721
4. Teri L, Lartson EB, Reifler BV: Behavioral disturbance in dementia of the Alzheimer's type. J Am Geriatr Soc 1988; 36:1-6
5. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15
6. Schneider LS, Pollock VE, Lyeness SA: A meta-analysis of controlled trials of neuroleptic. J Am Geriatr Soc 1990; 38:553-563
7. Kunik ME, Yudofsky SC, Silver JM, et al: Pharmacologic approach to the management of agitation associated with dementia. J Clin Psychiatry 1994; 55(suppl 2):13-17
8. Herrmann N, Rivard M, Flynn M, et al: Risperidone for the treatment of behavioral disturbances in dementia: a case series. J Neuropsychiatry Clin Neurosci 1998; 10:220-223
9. Tariot PN, Erb R, Leibovici A, et al: Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42:1160-1166
10. Tariot PN, Erb R, Podgorski CA, et al: Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155:54-61
11. Mellow AM, Solano-Lopez C, Davis S: Sodium valproate in the treatment of behavioral disturbances in dementia. J Geriatr Psychiatry Neurol 1993; 6:203-209
12. Lott DA, McElroy SL, Keys MA: Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry Clin Neurosci 1995; 7:314-319
13. Grossman F: A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy 1998; 18:600-606
14. Regan WM, Gordon SM: Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol 1997; 17:59-60
15. Sheldon L, Ancill RJ, Holliday SG: Gabapentin in geriatric psychiatry patients (letter). Can J Psychiatry 1998; 43:422-423
16. Taylor CP: Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44(suppl 5):S10-S16
17. Shorvan S, Stefan H: Overview of the safety of newer antiepileptic drugs. Epilepsia 1997; 38(suppl 1):S45-S51
18. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
19. Yudofsky SC, Kopecky HJ, Kunik M, et al: The Overt Agitation Severity Scale for the objective rating of agitation. J Neuropsychiatry Clin Neurosci 1997; 9:541-548
20. Devanand DP, Jacobs DM, Tang MX, et al: The course of psychopathologic features in mild to moderate Alzheimer's disease. Arch Gen Psychiatry 1997; 54:257-263